Body Recomposition Formula: Scientific Support for Fat Loss, Muscle Preservation & Metabolic Resilience

Many people struggle with body recomposition — the process of reducing body fat while preserving or increasing lean muscle mass — even when diet and exercise are on track. Traditional weight loss approaches often focus only on the scale, but true metabolic health requires optimizing body composition, not just body weight (Heymsfield et al., 2014).

At Hormone Treatment Centers, the Body Recomposition Formula incorporates evidence-based peptides that support the body’s natural repair, fat metabolism, and lean mass signaling — helping empower patients to meet their goals with precision and clinical oversight.

Understanding Body Recomposition

“Body recomposition” refers to the simultaneous reduction of adipose (fat) tissue and retention or increase of lean muscle mass. This approach aligns more closely with metabolic health than traditional weight loss because a higher proportion of lean muscle improves:

• Resting metabolic rate

• Insulin sensitivity

• Physical function and strength

• Post-exercise recovery

Maintaining or increasing muscle mass is especially important as adults age, since age-related muscle loss (sarcopenia) is associated with reduced metabolic health and physical resilience (Janssen et al., 2010).

Why Peptides? The Science Behind the Formula

Peptides are short protein fragments that act as signaling molecules to influence specific physiologic pathways. When used properly under medical supervision, select peptides can support metabolic processes, recovery, tissue adaptation, and fat metabolism in ways that complement diet and exercise strategies (Veldhuis et al., 2011).

The Body Recomposition Formula uses clinically studied peptides that support the body’s internal communication systems, helping optimize lean mass and metabolic performance.

Key Peptides in the Body Recomposition Formula

1. Tesamorelin: Growth Hormone Axis Support

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that stimulates endogenous growth hormone (GH) secretion. Clinically, tesamorelin has been shown to reduce visceral adiposity — a metabolically active fat depot linked with higher cardiometabolic risk — while preserving lean tissue (Falutz et al., 2010).

By supporting GH axis signaling within physiologic ranges, tesamorelin aids in balanced fat metabolism and lean mass maintenance.

Benefits:

• Enhanced fat reduction

• Lean muscle preservation

• Metabolic pathway support

2. AOD-9604: Targeted Fat Metabolism

AOD-9604 is a peptide fragment derived from human growth hormone that is optimized to support lipolysis (fat breakdown) without significantly altering blood glucose or IGF-1 levels (Ng et al., 2011). Its specificity makes it a useful adjunct to metabolic support plans.

Benefits:

• Fat mobilization support

• Minimal hormonal interference

• Enhanced metabolic responsiveness

3. MOTS-C: Mitochondrial Signaling and Metabolic Flexibility

MOTS-C is a mitochondrial-derived peptide that enhances metabolic flexibility and supports efficient energy usage within cells. Preclinical research shows that MOTS-C improves glucose uptake and cellular energy pathways, which may translate into improved metabolic performance (Lee et al., 2015).

Optimizing mitochondrial signaling is key for sustained fat oxidation and endurance.

Benefits:

• Improved metabolic signaling

• Support for glucose handling and energy

• Enhanced cellular resilience

How the Formula Works Together

Each component of the Body Recomposition Formula targets a complementary aspect of metabolic physiology:

• Tesamorelin supports GH axis integration

• AOD-9604 directly influences fat metabolism

• MOTS-C enhances cellular and mitochondrial energy signaling

Together, these peptides support a more holistic approach to body recomposition by influencing the signaling networks behind fat utilization, lean mass retention, and overall metabolic performance.

Science-Backed Benefits You Can Expect

Patients using the Body Recomposition Formula, combined with proper nutrition and exercise, often report measurable improvements in:

• Reduced visceral and subcutaneous fat

• Increased lean muscle mass or muscle tone

• Improved energy and metabolic efficiency

• Faster recovery and reduced exercise fatigue

• Greater endurance and workout performance

These outcomes align with what clinical and mechanistic research suggests about peptide-assisted metabolic modulation and cellular optimization.

Integrating with a Personalized Plan

At Hormone Treatment Centers, the Body Recomposition Formula is implemented as part of a comprehensive, data-driven program that includes:

• full hormonal and metabolic lab profiling

• customized peptide dosing protocols

• body composition assessment

• personalized nutrition and exercise guidance

• ongoing clinical monitoring

This ensures that patients receive a tailored plan that addresses the unique metabolic and physiologic variables influencing their recomposition success.

Real Change Is a Holistic Process

Body recomposition is not about “quick fixes” or temporary tricks; it’s about optimizing internal physiology so that fat loss and lean mass gain can happen more effectively and sustainably. The peptides in the Body Recomposition Formula support the communication pathways that govern metabolism, energy, and tissue adaptation — and when combined with lifestyle elements, create a powerful platform for lasting improvement.

Works Cited

Falutz, J., Allas, S., Blot, K., Potvin, D., Kotler, D., Somero, M., … Grinspoon, S. (2010). Metabolic effects of a growth hormone–releasing factor in patients with HIV. New England Journal of Medicine, 363(5), 423–431.

Janssen, I., Heymsfield, S. B., & Ross, R. (2010). Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment. Journal of the American Geriatrics Society, 50(5), 889–896.

Lee, C., Kim, K. H., & Cohen, P. (2015). MOTS-C: A mitochondrial-derived peptide regulating metabolic homeostasis. Cell Metabolism, 21(3), 443–454.

Ng, F. M., et al. (2011). Effects of hGH fragment 176–191 on adipose tissue metabolism. Endocrine Research, 36(2), 52–62.

Veldhuis, J. D., et al. (2011). Mechanisms regulating growth hormone secretion and action. Endocrine Reviews, 32(5), 651–670.